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Identifying subpopulations in multicellular systems
by quantitative chemical imaging using label-free
hyperspectral CARS microscopy†
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Wolfgang Langbein *c
Quantitative hyperspectral coherent Raman scattering microscopy merges imaging with spectroscopy
and utilises quantitative data analysis algorithms to extract physically meaningful chemical components,
spectrally and spatially-resolved, with sub-cellular resolution. This label-free non-invasive method has the
potential to significantly advance our understanding of the complexity of living multicellular systems.
Here, we have applied an in-house developed hyperspectral coherent anti-Stokes Raman scattering
(CARS) microscope, combined with a quantitative data analysis pipeline, to imaging living mouse liver
organoids as well as fixed mouse brain tissue sections xenografted with glioblastoma cells. We show that
the method is capable of discriminating different cellular sub-populations, on the basis of their chemical
content which is obtained from an unsupervised analysis, i.e. without prior knowledge. Specifically, in the
organoids, we identify sub-populations of cells at different phases in the cell cycle, while in the brain
tissue, we distinguish normal tissue from cancer cells, and, notably, tumours derived from transplanted
cancer stem cells versus non-stem glioblastoma cells. The ability of the method to identify different sub-
populations was validated by correlative fluorescence microscopy using fluorescent protein markers.
These examples expand the application portfolio of quantitative chemical imaging by hyperspectral CARS
microscopy to multicellular systems of significant biomedical relevance, pointing the way to new oppor-
tunities in non-invasive disease diagnostics.
1. Introduction
It is becoming increasingly important in modern biomedical
research to develop analytical tools capable of dissecting the
complexity of multicellular systems, such as tissues and organs,
without perturbing their natural state. Optical microscopy is still
the only practical means to observe living specimens at sub-cellu-
lar spatial resolution in three dimensions and in real time. A
major challenge of optical microscopy applied to cell biology is
chemical specificity, since many biomolecules do not selectively
absorb or emit light in the visible range.
Albeit some endogenous biomolecules do exhibit dis-
tinguishable autofluorescence emission, for example flavins
and lipo-pigments,1 a widely utilized method to introduce
chemical contrast is by means of exogenous fluorescent labels
with high absorption cross-sections and quantum yields
attached to biomolecules of interest. However, all organic fluo-
rescent probes are prone to photobleaching, and associated
phototoxicity, severely limiting long time-course observation in
living specimens. Moreover, the process of labelling is often
time-consuming, invasive, and can introduce staining artefacts.
Over the past two decades, vibrational microscopy exploiting the
phenomenon of Raman scattering has emerged as a powerful
label-free, chemically-specific modality complementing fluo-
rescence.2 Spontaneous Raman scattering cross-sections of bio-
molecules are notoriously small, with corresponding limitations
in imaging speed and sensitivity. The development of coherent
Raman scattering (CRS) microscopy3 is partially circumventing
these limitations, owing to the constructive interference of
Raman light scattered by identical bonds in the focal volume,
coherently driven to vibrate in phase.
Many of the earlier demonstrations of CRS microscopy4,5
showed images acquired at a single vibrational resonance,
often chosen at the CH2 symmetric stretch vibration around
2850 cm−1, which is abundant in lipids. However, it is well
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known from Raman micro-spectroscopy that the best chemical
specificity is obtained when acquiring vibrational spectra
spanning a relevant range of wavenumbers, at each spatial
position. Such combination of imaging with spectroscopy in
CRS, often called hyperspectral CRS microscopy, has seen
various experimental implementations whereby spectra at each
spatial point are acquired at once6 using a spectrometer with a
camera, or sequentially, by tuning the excitation wavelength7
or via spectral focusing.8 Hyperspectral acquisition has signifi-
cantly widened the application space of CRS microscopy, with
recent reports showing the spatial distributions of not only
lipids, but also proteins, water, and nucleic acid components
inside cells9–11 and tissues,6,7,12 as well as the ability to dis-
tinguish different lipid types, such as saturated versus unsatu-
rated fatty acids,13,14 cholesterol,15 and phospholipids.16
Building from these capabilities, the application of CRS
microscopy to tissue analysis for disease diagnostics in histo-
pathology has been gaining increasing attention.17–19 Notably,
the photo-stability and reproducibility of CRS micro-spec-
troscopy makes it a quantitative technique, with the potential
to overcome qualitative and subjective decision making pro-
cesses in current medical practice, suffering from high degrees
of variability.
The combination of hyperspectral CRS data acquisition
with quantitative image analysis algorithms is an area which
has received major interest in recent years. Broadly speaking
there are two main ways in which hyperspectral data sets, con-
sisting of CRS signals as a function of spatial and spectral
coordinates, are visualised. Some groups report spatially-
resolved CRS intensities, or retrieved Raman-like suscepti-
bilities, at selected wavenumbers, the latter attributed to
characteristic vibrational resonances thought to be specific of
certain biomolecular species.17 Pseudocolor images are then
formed by assigning colours to single-frequency spatial distri-
butions and overlay them to highlight differences in spatial
patterns, which in turn can serve as markers of e.g. sub-cellu-
lar structures (such as nuclei), or diseased versus normal cells
in tissues.6,12 A more advanced quantitative approach consists
in factorising hyperspectral data sets into the superposition of
separate components having characteristic spectra, and visua-
lising the spatially resolved map of the components. A few
methods have been proposed in the latter approach, including
principal component analysis20 and independent component
analysis.7 However, these methods usually are not able to
make an unsupervised decomposition into individual chemi-
cal species with absolute concentration determination, which
is ultimately the most meaningful quantitative representation.
We have developed over the past years a hyperspectral
coherent anti-Stokes Raman scattering (CARS) microscope and
an unsupervised quantitative data-analysis algorithm which
allows us to retrieve Raman-like spectra and spatially-resolved
concentration maps of chemical components, in physically
meaningful units, with no prior knowledge.9–11,16,21 The
method has so far been applied to 2D cell cultures, and its
capability to dissect more complex features in multicellular
systems such as 3D cell cultures and tissues has not yet been
showcased. In this work, we report the application of this
method on two exemplar multicellular systems, namely mouse
liver organoids and mouse brain tissues xenografted with glio-
blastoma (GBM) cells.
Organoids are 3D micro-physiological structures of
20–400 μm diameter formed from clusters of parenchymal
cells that grow and self-organise within gels formed from
matrix components. The careful definition of growth factor
combinations has allowed organoids to be established from a
range of normal tissues and from pathological samples, using
both mouse models and cells extracted from humans/
patients.22 Organoids are already the system of choice for the
identification of therapies in conditions such as Cystic
Fibrosis and are starting to emerge as systems for cancer drug
discovery in personalised medicine, since they better recapitu-
late patient responses than 2D cancer cell lines.
Advances in cancer research over the last decade have high-
lighted molecular differences at the single cell level within the
same cancer and have led to a greater recognition of the
degree of heterogeneity within tumors. The brain cancer glio-
blastoma is one of the most heterogeneous types of cancer and
its rapid progression has been linked to a subpopulation of
cancer cells known as GBM cancer stem cells (GSCs).23 GSCs
are capable of initiating and sustaining tumor growth and are
more resistant to conventional therapies.24,25 GSCs also con-
tribute to metabolic heterogeneity in brain cancer26 and it was
previously shown that GSCs preferentially utilize lipid metab-
olism, while non-stem GBM cells (NGC) depend on glucose.27
Hence, profound biochemical differences exist between GBM
cellular subsets. Most studies investigating tumor heterogen-
eity in GBM and other cancers rely on transcriptional profiling
or other biochemical characterization of cancer cells which
necessitate sample lysis and therefore cannot be performed on
living cells. Live cell imaging studies shown so far critically
depend on labels (fluorescent or otherwise) to enable detec-
tion of chemical changes within cells, which is limited by the
chemical sensitivity and read-out of the reporter.
Here, we have investigated whether our quantitative label-
free CARS microscopy method can be used to discriminate
different cellular subpopulations within organoids and brain
tissues, based on their endogenous chemical content.
Specifically, we address if cells can be distinguished while at
different phases during the cell cycle in liver organoids, and if
GSCs versus NGCs can be separated in brain tissues.
2. Materials and methods
2.1. Sample preparation – Fucci2aR liver bile duct organoids
2.1.1. Mice. The Fucci2aR construct, a fluorescence ubiqui-
tination-based cell cycle indicator, is used to identify where a
cell is within its cell cycle. Mice containing the bicistronic
R26–Fucci2aR allele28 in the Rosa26 locus express the
mCherry-hCdt and the mVenus-hGem fusion proteins upon
expression of Cre protein. The mCherry-hCdt proteins and the
mVenus-hGem proteins are only stable in the G1 and S/G2/M
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phases of the cell cycle, respectively. To be able to induce
expression of the Fucci2aR construct in liver cells, R26–
Fucci2aR allele mice in C57Bl/6-FvB background were crossed
with C57Bl/6-FvB background mice bearing the Ahcre allele29
that strongly expresses the Cre protein in liver cells after
administration of β-naphthoflavone. Mice were genotyped by
PCR for presence of the R26–Fucci2aR and Ahcre alleles as
described.28,29 Mice were held at the Beatson Institute,
Glasgow on a 12 h light/dark cycle with free access to standard
chow and water. To induce expression of the Fucci2aR con-
struct, mice were injected intraperitoneally with 80 mg kg−1
β-naphthoflavone daily for 4 days using an 8 mg ml−1
β-naphthoflavone (Sigma, N3633) solution in corn oil (Sigma,
C8267).
2.1.2. Organoid culture. Mice were euthanised on the day
after the final β-naphthoflavone injection and liver tissue dis-
sected out. Liver bile duct organoid cultures were derived from
diced liver fragments and were cultured and passaged as
described using the Expansion Medium formulation.30 To
optimise fluorescence strength, liver bile duct cultures were
trypsinised to single cells with TrypLE (Thermo-Fisher,
Invitrogen) and gated on a BD FACSDiva 8.0.1 (Becton
Dickson) for the strongest mCherry-hCdt fluorescence which
were used in subsequent experiments. To set up cultures for
imaging, a piece of silicone gasket containing four holes of
3 mm diameter was cut from a 1 mm thick CultureWell gasket
(Grace Bio-Labs, SKU: 103250), ethanol-sterilised and put in
the middle of a low profile, uncoated, sterile 35 mm diameter
Dish (Ibidi, IB-80131). After passage of liver bile duct orga-
noids, 8 μl of Growth Factor Reduced Matrigel (Corning,
354230) containing liver bile duct organoid fragments was
pipetted into each well in the gasket and allowed to set (at
37 °C for 5 min). The cultures were then covered in medium.
Lids were replaced with differential interference contrast (DIC)
glass insert lids (Ibidi, IB-80050) for DIC imaging. Cultures
were imaged 2–3 days after seeding.
2.2. Sample preparation – brain tissues with GBM
Human glioblastoma cell line L0 was a kind gift from Prof.
Brent Reynolds (University of Florida) and was cultured as
described previously.31 Briefly, cells were lentivirally trans-
duced to express the green fluorescent protein eGFP and main-
tained as sphere cultures in N2 medium containing 20 ng
ml−1 EGF. For orthotopic implantation of GSC and NGC popu-
lations, glioblastoma cells were dissociated, and single cell
suspensions immunostained using a mouse monoclonal anti-
body against FGFR1 (Thermo Fischer, 1:50 dilution) and
appropriate secondary antibody (Thermo Fischer, 1:500), and
purified by FACS.31 Orthotopic xenografts of FGFR1 + (GSC)
and FGFR1-(NGC) populations (10 000 cells per animal each)
were performed in 4–6 weeks old female SCID mice.31 Animal
care and handling, and all procedures were performed in
accordance with FELASA and institutional guidelines of
Cardiff University and approved by the Animal Welfare Ethical
Review Body of Cardiff University and the UK home office
(PPL30/3331). Mice were maintained under Isoflurane anesthe-
sia during procedures. Mice were monitored daily for the
development of neurological signs and body weight loss.
Animals reaching endpoint criteria were transcardially per-
fused using 2% paraformaldehyde and the brains removed for
histology. Tissue preparation and cryosectioning was per-
formed as described by Jimenez-Pascual et al.31 Briefly, 30 μm
thick sections were cut on a cryomicrotome and stored in cryo-
protectant until use. For CARS microscopy, tissue sections
were mounted onto glass slides and air dried before being
reconstituted with double-distilled water (ddH2O). Prior to
imaging, sections were covered with a #1.5, 24 × 24 mm cover-
slip (Menzel Gläser, Agar Scientific AGL46S24-15) and sealed
with nail varnish. Endogenous eGFP expression in GBM cells
was used to discriminate between tumour and host cells.
2.3. Optical micro-spectroscopy
Imaging of both the living organoids and fixed glioblastoma
tissues was performed on the same inverted microscope
(Nikon, Eclipse Ti-U). Alongside conventional wide-field epi-
fluorescence and DIC imaging, the microscope has been modi-
fied to enable two-photon fluorescence (TPF) and hyperspec-
tral CARS imaging modalities, described in our previous
work.8 A home-built environmental chamber surrounds the
microscope allowing a constant temperature of 37 °C with a
5% CO2/air-blend environment to be maintained for live cell
imaging. Both sets of measurements used a 40 × 1.15 NA
water-immersion objective (Nikon, MRD77410 CFI Plan
Apochromat λS series) with a 1.0 × tube lens. A 1.34 NA oil-
immersion condenser lens (Nikon, MEL41410) was used with
the fixed glioblastomas, while a 0.72 NA dry condenser (Nikon,
MEL56100) was used with the organoids to accommodate the
low profile dish and lid of the CO2 chamber. xy sample motion
and z objective motion are automated by stepper motors
(Prior, ProScan III controller (V31XYZ), xy stage (H117NN2N)
and z drive (PS3H122)).
2.3.1. Wide-field DIC and epi-fluorescence microscopy. A
CCD camera (Hamamatsu, Orca 285) with 1344 × 1024 pixels
6.45 μm in size is used for both DIC and fluorescence acqui-
sition. Considering the 40× magnification, the pixel size
corresponds to 0.163 μm at the sample plane. The camera has
9 e read noise and 18 ke full-well capacity. The images are digi-
tized by a 12-bit A/D converter and saved to 16-bit greyscale
TIFF format.
DIC illumination was provided by a halogen tungsten lamp
(Nikon, V2-A LL 100 W) followed by a blue-green filter (Schott,
BG40) to block near-infrared light, for which the DIC polari-
sers do not have sufficient extinction. A red bandpass filter
(ThorLabs, FB650-40 (650 ± 20) nm) is used to define the wave-
length range; the longer (red) wavelengths penetrate further
into the organoids and do not excite fluorescence, avoiding
photobleaching. A de Sénarmont compensator (Nikon,
MEN51941 T-P2 DIC Polarizer HT) is used for DIC offset phase
adjustment, consisting of a polarizer and a quarter-wave plate
in the illumination beam path. The angle θ of the polarizer
with respect to the fast axis of the quarter-wave plate is adjus-
table. The compensator is followed by a Nomarski prism in
Analyst Paper



























































































the condenser unit (Nikon, MEH52500 HNA N2 Oil, with the
1.34 NA oil-immersion condenser, or Nikon, MEH52400 CLWD
N2, with the 0.72 NA dry condenser). A second Nomarski
prism is placed after the objective (MBH76245 D-C DIC Slider
40X-II, Nikon), followed by a linear polariser (Nikon,
MEN51980 Ti-A-E DIC Analyzer Block) in the filter turret. DIC
phase angle setting for the organoids was θ = 45°, and for the
brain tissues was θ = 0° (no background transmission) and θ =
40°. An exposure time of 0.1 s was used for all DIC experi-
ments. The lamp illumination intensity was set to result in a
maximum image pixel value around 15 ke, corresponding to
about 2 mW cm−2 at the sample for the 40° and 45° rotation
angles and about 70 mW cm−2 for the 0° rotation angle.
For the brain tissue samples, wide-field epi-fluorescence
excitation of eGFP was provided by a metal–halide lamp (Prior
Scientific, Lumen L200/D) set at 10% of the maximum power.
A suitable exciter/emitter/dichroic filter cube (Semrock, GFP-A-
Basic) was used, resulting in an illumination intensity of about
3 W cm−2 at the sample. Fluorescence images were acquired
with an exposure time of 0.03 s.
2.3.2. TPF and hyperspectral CARS microscopy. Two-
photon fluorescence and hyperspectral CARS microscopy
images were acquired using the experimental setup described
in our previous work8 with some minor upgrades, as indicated
below. Briefly, we use a single broadband 5 fs pulsed laser-
source, with a pulse spectral width of 310 nm at 10% of the
maximum intensity (660 nm to 970 nm) at a repetition rate of
80 MHz (Venteon, Pulse:One PE). A long-pass filter consisting
of two 2.5 mm thick Hoya R66 filters at Brewster angle rejects
the short wavelength laser beam tail, having a steeper cut-off
than the Schott RG645 used previously. Dichroic beamsplitters
separate the laser beam into the pump and Stokes beams for
CARS (CVI Melles Griot, LWP-450RP670-TP830-PW-1025-C),
and a third beam (Eksma Optics, custom short-pass) for two-
photon excitation (TPE) of fluorescence. The pulses are peaked
at 685 nm (pump), 806 nm (Stokes) and 940 nm (TPE), with a
bandwidth at 10% intensity of 65 nm, 200 nm and 70 nm,
respectively. A prism-based pulse compressor is used to obtain
TPE pulses with a Fourier-limited pulse duration of approxi-
mately 30 fs at the sample. Spectral focussing with glass
elements34 is implemented to achieve narrow-band CARS spec-
tral resolution and wavenumber tuning from the broadband
pulses. Vibrational frequencies between 1200 and 3800 cm−1
can be addressed by varying the instantaneous frequency
difference (IFD) between pump and Stokes pulses, which is
controlled by adjusting the relative delay time between the
pulses with an optical delay line (PI, M-404.42S). Additional
glass elements in the Stokes beam path tune the Stokes linear
chirp to match that of the pump pulse, enabling a high spec-
tral resolution of 10 cm−1 to be achieved. The pump, Stokes
and TPE beams are recombined using the same dichroic
beam-splitters used to split them prior to entering the scan
mirrors (Cambridge Technology, 6210HSM40). A scan lens
(from a Nikon, A1RMP multiphoton microscope) is used to
focus the collimated beam from the scan mirrors into the
intermediate image plane at the microscope port, and image
the scan mirrors onto the back focal plane of the microscope
objective. Signals are collected in the forward direction by the
condenser lens and detected as shown in Fig. 1(a). A dichroic
beamsplitter DM1 (Semrock FF538-FDi01) transmits CARS at
wavelengths >540 nm and reflects signals at shorter wave-
length. In the CARS detection path, a pair of bandpass filters
F1 (Semrock FF01-562/40 for the 2500–3800 cm−1 range)
rejects the excitation laser (by more than 13 orders of magni-
tude) and the transmitted light is detected by the CARS photo-
multiplier (PMT; Hamamatsu, H7422-40). The signal reflected
by DM1 travels through a second dichroic beamsplitter DM2
(Chroma t495lp) which reflects wavelengths below 495 nm,
such as second harmonic generation of the TPE beam8 (not
used here), and transmits TPF. A pair of bandpass filters F2
(Semrock FF01-510/84) rejects the excitation laser and trans-
mits the TPF to the PMT (Hamamatsu, H10770A-40). DM1 and
the TPF PMT have been upgraded from our original setup
description.8 The resulting quantum efficiency spectra of the
CARS and TPF PMT detection channels are shown in Fig. 1
together with the relevant two-photon absorption and emis-
sion spectra of the fluorophores used.
2.3.2.1. Organoid acquisition settings. Organoids were first
located using DIC, as described above. TPF and hyperspectral
CARS images were acquired sequentially to avoid bleaching of
TPF by the CARS excitation, as well as bleed through of TPF
into the CARS detection, see results section for discussion.
TPF images and hyperspectral CARS z-stacks were acquired at
1 μm and 5 μm intervals respectively, over a z-range of 30 μm.
The pixel size in the x, y plane was (86 nm)2. A pixel dwell time
of 100 μs and 1 μs and PMT gains of 106 and 104.6 were used
for TPF and CARS, respectively. Typical excitation powers at
the sample were 41 mW (pump), 31 mW (Stokes) and 11 mW
(TPF). Hyperspectral (x, y and wavenumber) CARS scans were
acquired over the range 2600–3800 cm−1, with 5 cm−1 step
size. Following each scan, an image was acquired with the
pump and Stokes pulses out of time overlap (all other settings
identical) to measure non-CARS background.
2.3.2.2. Brain tissue acquisition settings. Wide-field fluo-
rescence and DIC were first used to locate GSCs and NGCs
within the brain section. TPF and hyperspectral CARS images
were acquired sequentially to avoid bleed through of the
strong fluorescence signal into the CARS detection, see results
section for discussion. PMT gains of 104.8 and 105 were used
for TPF and CARS, respectively with a pixel dwell time of 10 μs
for both. The pixel size in the x, y plane was (80 nm)2. Typical
excitation powers at the sample were 31 mW (pump), 23 mW
(Stokes) and 8 mW (TPF). Hyperspectral CARS scans were
acquired over the range 2600–3700 cm−1, with 5 cm−1 step
size. Following each hyperspectral CARS scan, an image was
acquired with the pump and Stokes pulses out of time overlap
(all other settings identical) to determine background offset
levels.
2.4. CARS hyperspectral analysis
Hyperspectral CARS datasets can be difficult to visualise and
interpret, and for this purpose we have developed the
Paper Analyst



























































































Hyperspectral Image Analysis (HIA) software.9 HIA enables the
retrieval of the imaginary part of the CARS susceptibility
= χ̄ð Þð Þ and the factorisation of the spectra into a specified
number of chemical components with corresponding concen-
tration maps. Briefly, the HIA pipeline operates as
follows.9,35,36 Firstly, a background image acquired with the
pump and Stokes beams out of time overlap is subtracted
from each image of the hyperspectral CARS scan. As well as
subtracting backgrounds e.g. from the electronics, this step
also removes potential fluorescence contributions generated
from the individual pulses. Singular-value decomposition
(SVD) is then employed to denoise the data. In order to correct
for the varying temporal overlap of the pump and Stokes
beams, data are divided by the spectrum of a non-resonant
material (glass), acquired with the same laser power and acqui-
sition settings. If there is a region filled with water present in
the image, this may be used as reference material, combined
with a previously calibrated glass/water ratio. If there is no
such region present (as with the brain tissue samples), a glass
spectrum is measured in the glass coverslip immediately after
the acquisition of the CARS data on the sample. To enable
quantitative analysis, the imaginary part of the CARS suscepti-
bility = χ̄ð Þð Þ is retrieved using a phase-corrected Kramers–
Kronig (PCKK) procedure, which recovers a Raman-like spec-
trum. Finally, the retrieved spatially-resolved susceptibility
spectra are factorised into spectra and spatially-resolved con-
centration maps of chemical components (a method which we
called FSC3), based on non-negative matrix factorisation. We
use an iterative algorithm37 where concentration maps and
spectra are sequentially varied to minimise the factorisation
error. Importantly, the factorisation is unsupervised, i.e. it
does not require prior knowledge of the sample’s chemical
composition. The number of components used in the factoris-
ation can be varied, with the optimal number being the
minimum required to provide unique spatial and spectral fea-
tures. Typically, in the range of 6 to 7 components are needed,
with 5 to 6 components being physically meaningful, and 1 or
2 components accounting for spurious noise and imaging arte-
facts. To reduce the importance of water, which is dominating
the = χ̄ð Þ spectra above 3100 cm−1, the spectral range analysed
by FSC3 is typically limited11 to a maximum of 3150 cm−1,
which retains the relevant vibrational resonances of the
organic material. FSC3 may be applied to hyperspectral data
sets individually, or multiple sets can be analysed together. It
is also possible to take components from a selected factoris-
ation analysis, and use these as a base to factorise other data
sets. This is referred to as projection, and uses a single step of
the factorisation algorithm which calculates the concentration
maps, while keeping the spectra fixed to the given base.
3. Results and discussion
3.1. Fucci2aR liver bile duct organoids
Liver organoids investigated here incorporated the fluo-
rescence ubiquitination-based cell cycle indicator (Fucci2aR)
Fig. 1 (a) Forward detection layout. A dichroic beamsplitter (DM1)
transmits the CARS emission at wavelengths >540 nm and reflects the
TPF emission at shorter wavelengths. In the CARS detection path, a pair
of bandpass filters (F1) rejects unwanted signals from reaching the CARS
PMT. The signal reflected by DM1 travels through a second dichroic
mirror (DM2) which reflects wavelengths below 495 nm. A pair of band-
pass filters (F2) rejects unwanted signals from reaching the TPF PMT. (b)
Normalized two-photon excitation (dashed lines) and emission (solid
lines) spectra for the mVenus32 (green) and mCherry33 (red) fluorescent
proteins in the Fucci2aR system. (c) Normalized two-photon excitation33
(dashed line) and emission (solid line) spectrum of eGFP used in the glio-
blastoma tumour cells. Also plotted are the normalized TPF excitation
pulse spectrum (grey infill curve, at half its wavelength) and the
quantum efficiency of the TPF (orange) and CARS (black) PMT detection
from the entrance into DM1.
Analyst Paper



























































































system (see section 2.1.1). This is a fluorescent protein-based
construct that employs a red (mCherry) and a green (mVenus)
fluorescent protein fused to two cell cycle dependent proteins,
Cdt1 and geminin, respectively. In eukaryotic cells, Cdt1 level
peaks during G1 phase and plummets upon S entry.
Conversely, the geminin level is high during S, G2 and M
phases, and is degraded in the subsequent G1 phase.
Therefore, when cells are in the G1 phase, the high level of
mCherry gives rise to red-fluorescent cell nuclei, whilst in the
S/G2/M phase the high level of mVenus results in green-fluo-
rescent nuclei. We used this construct as a fluorescence
marker, enabling direct correlation of TPF and hyperspectral
CARS imaging on the same living organoid, to investigate
whether hyperspectral CARS is able to distinguish subpopu-
lation of cells at different phases in the cell cycle. The experi-
ment was set-up to avoid bleed-through between fluorescence
emission and CARS detection, as detailed in the following.
The two-photon excitation and emission spectra for mCherry33
and mVenus32 are displayed in Fig. 1(b) overlaid with the spec-
trum of the TPE beam, and with the TPF and CARS PMT detec-
tion quantum efficiency (QE) spectra for the optical setup.
mCherry is excited only weakly by the TPE beam, and its emis-
sion lies above the detection ranges of both the TPF and CARS
PMTs. Therefore, no fluorescence signal is observed from
cells in the G1 phase under these excitation/detection con-
ditions. Conversely, the mVenus TPE spectrum overlaps well
with the TPE pulse spectrum, and the peak of its emission
falls within the detection range of the TPF PMT. There is also
an overlap of the mVenus emission spectrum with the CARS
PMT detection range. Under TPE beam excitation, we therefore
observe a strong signal detected by the TPF PMT, and a weaker
signal from the CARS PMT, from those cells that are in the
S/G2/M phase of their cell cycle. This is demonstrated by the
images in Fig. 2(a and d) which show the signal in an xy plane
sectioning the organoid, detected by the TPF and CARS PMTs
when the sample is excited only by the TPE beam. For com-
parison, Fig. 2(b and e) illustrates the detected signal when the
sample is excited only by the CARS (pump and Stokes) beams
at 2850 cm−1 IFD. Here, we observe a strong signal in the
CARS PMT from lipids and proteins in the cell cytoplasm, with
the cell nucleus appearing dark. The organoid forms a hollow
structure, as can also be seen in the DIC images (Fig. 2(g–i))
taken at different z-planes through the organoid. A signal from
the cell cytoplasm is observed in the TPF PMT under CARS
excitation. This is originating from two-photon excited auto-
fluorescence, as can be seen in Fig. 2(c and f) which illustrates
the observed signal when the sample is excited by the pump
and Stokes beams out of time overlap (i.e. there is no CARS
signal generated). Such autofluorescence is predominantly
generated by the pump beam, considering the pump pulse
TPE peak at around 340 nm.38 Fig. 2(c and f) also demon-
strates that there is no fluorescence detected by the CARS PMT
under pump and Stokes excitation when the pulses are not in
temporal overlap. To maintain such de-coupling, TPF and
CARS images were acquired sequentially, rather than simul-
taneously, throughout the experiments.
TPF images were acquired in 3D, as z-stacks with 1 μm
intervals, while hyperspectral CARS z-stacks were acquired at
5 μm steps through the organoid (see section 2.3.2.1). This
choice was made in order to compromise between 3D imaging
and the time required for hyperspectral CARS acquisition,
while minimising motion artefacts and photodamage, since
organoids were alive. The TPF z-stack is used to positively
identify the cells in the S/G2/M phase of their cell cycle and
generate a 3D reconstruction of their position for correlation
with the hyperspectral CARS data. A xy slice with z-projection,
along with a 3D rendering of the TPF z-stack is presented in
Fig. 3. An overview of all xy planes is shown in Fig. S1.† The
TPF volumetric dataset was then quantitatively analysed, as
follows. Cell nuclei volumes were calculated from the 3D
reconstruction using the 3D Objects Counter plugin39 for the
image analysis software ImageJ to segment the nuclei (see
section S1 ii and Fig. S2†). The fluorescence intensity inte-
grated over the nucleus volume is given in Fig. 3(d) versus
nucleus volume for each cell which showed localization of TPF
in the nucleus. A clear trend of increasing fluorescence inten-
sity with increasing nucleus volume is observed, consistent
with the progressive increase of the size of a cell and its
nucleus during the eukaryotic cell cycle,40–42 and that mVenus-
geminin is highly expressed in the later phases of the cycle,
once the cell has started its DNA replication. Notably, we
observe a step in the intensity increase for intermediate cell
volumes between 300 μm3 and 400 μm3, which is clearly
visible in the average intensity over the nucleus volume, as
shown in Fig. 3(e). The correlation between nucleus size and
mVenus fluorescence intensity suggests that low-intensity
small-nucleus cells are at the G1/S phase, intermediate sized
nuclei with high intensity are in the S/G2 phase, and large
nuclei are in the G2/M phase.
Hyperspectral CARS was quantitatively analysed using the
HIA/FSC3 pipeline as described in section 2.4. The resultant
susceptibility spectra and concentration maps measured at the
same xy plane as shown in Fig. 3 are presented in Fig. 4. Seven
spectral components were used. Based on the retrieved suscep-
tibility spectra and the spatial profile of the concentration
maps, the first six components were attributed to c1: water, c2:
protein, c3: nucleic acids + protein (PNA), c4: DNA, c5: lipid, c6:
lipid + protein. This is consistent with published reports9,11,43
showing that: (i) water has a Raman spectrum peaked at
around 3300 cm−1, hence appears as a tail in the
2800–3200 cm−1 range; (ii) the ratio between the CH2 sym-
metric stretch vibration (2850 cm−1) and the CH3 resonance
(2930 cm−1) discriminates between lipids (rich in CH2 bonds)
and proteins (peaked at 2930 cm−1); (iii) nucleic acids exhibit
Raman spectra peaked at 2950 cm−1 and DNA is confined to
the cell nucleus. We note that all components contain a sig-
nificant amount of water additional to the attributed organic
material. c4 is dominated by a water contribution. The water-
subtracted spectrum of this component (see Fig. S9†) shows a
spectral distribution between 2900 and 3100 cm−1 consistent
with the main features of DNA (see ref. 43 Fig. 1B). The spec-
tral shape and concentration map of c7 indicates that this is
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not a physically meaningful chemical component, and is attribu-
ted to imaging or sample motion artefacts (see Fig. S3, and S6†
for an overview of concentration and spectral errors). Inspection
of the concentration maps reveals that there is no obvious chemi-
cal component that can be directly correlated with the mVenus
marker. Indeed, while during the cell cycle it is known that the
amount of proteins and nucleic acids is growing in preparation
for mitosis, at the same time, the cell increases its volume at a
steady rate, hence it is unclear whether the concentration of
these components should be significantly altered during the
cycle. On the other hand, it has been shown, using yeast as
model systems of the eukaryotic cell cycle,41,42 that despite the
sharp increase in DNA copy number during DNA replication in
the S-phase, the size of the cell nucleus does not abruptly
increase in parallel, suggesting that the DNA concentration could
be significantly higher at the end of the S phase.
Fig. 2 Examples of CARS and TPE excitation and detection data on living Fucci2aR liver bile duct organoids. (a–c) Signal detected by the TPF PMT;
(d–f ) signal detected by the CARS PMT; (a and d) TPE excitation; (b and e) CARS excitation at 2850 cm−1 IFD; (c and f) CARS excitation with pump
and Stokes pulses out of time overlap. Image grey scale from 0 to M × 106 photoelectrons per second as indicated. (g–i) DIC images (+45° polariser
rotation angle) taken at three different z positions (see inset in image for z value) through the organoid, z = 0 μm is defined as the bottom of the
organoid. The z position of the CARS/TPF data shown above is approximately 15 μm, however DIC images are taken 30 min earlier, prohibiting an
exact correlation due to organoid development. Images grey scale as given in photoelectrons per second per pixel. Scale bars 10 μm.
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To investigate this point, we analysed all available hyper-
spectral CARS datasets for the different z-planes, using the
seven components shown in Fig. 4 as common basis (projec-
tion analysis, see Materials and methods). On these data sets,
we identified those cells that exhibited TPF of mVenus in the
nucleus, and calculated the average concentration of each
component over the nucleus area. Since hyperspectral CARS
z-stacks were performed with coarse 5 μm steps, well above
Nyquist sampling, we could not examine the retrieved concen-
tration components volumetrically in 3D. For each cell, we
therefore selected the z-planes where the nucleus area
appeared largest, as to avoid z-planes too close to the nucleus
top/bottom edges (see also Fig. S10†). This is to ensure that
the measured concentrations are only sampling the nucleus
region, considering the 1.5 μm wide axial point-spread func-
tion of = χ̄ð Þ for the data shown. Concentrations of c2 to c6
were scaled to represent dry values, by removing the water con-
tribution, as described in our recent work.11 Briefly, for each
component, we calculated the dry volume fraction γdi , to obtain
the corresponding dry vol/vol concentration γdi Ci. Details on
the determination of γdi are given in section S1 iv.† Fig. S11†
shows γdi Ci averaged over the nucleus area, for each cell that
exhibited TPF of mVenus in the nucleus, taken at the selected
z-plane (as explained above), as a function of the nucleus
volume. Since c3 and c4 both are localized in the nucleus and
have a spectrum comprising DNA, we considered the sum of
these two components, which is shown in Fig. 4(c). Notably,
we see that this sum γd3C3 + γ
d
4C4 sharply increases with
increasing nucleus volume around 350 μm3, following a
similar trend as the TPF intensity, which we attributed as sig-
nature of the S/G2 phase. The subsequent decrease of this con-
centration for large nuclei volumes in the G2/M phase, when
the DNA replication has ended, is in line with the expansion of
the nucleus size in preparation for mitosis while no longer
increasing its DNA content. The spread of concentration
values for different z-planes of one cell around 450 μm3
nucleus volume could also be indicative of an asymmetric dis-




γdi Ci is shown in Fig. 4(d), and appears approxi-
mately constant versus nucleus volume. The overview of each
component given in Fig. S11† shows that individual com-
ponents do not exhibit a well defined trend. Indeed, only γd3C3
+ γd4C4 appears to correlate with the TPF intensity dependence,
suggesting that this combination could be used as a marker of
the S/G2 phase in the cell cycle. For consistency, we also exam-
ined the cells imaged by hyperspectral CARS that did not exhibit
a significant mVenus TPF in the nucleus. Fig. 4(c) shows the
mean of γd3C3 + γ
d
4C4 over these cells (purple data points). We
considered two cases: all the non-fluorescent nuclei areas, and a
sub-set whereby we excluded nuclei with very small areas
(< 22 μm2), which could be too close to the top/bottom nucleus
edges, as well as nuclei with large areas (> 53 μm2), to exclude
cells beyond the G1 phase. The two purple data points represent
the mean for these two sets. An overview of γd3C3 + γ
d
4C4 for each
cells in the two sets, and the resulting mean, standard devi-
ation, and standard error of the mean is shown in Fig. S12.† For
the non-fluorescent cells we used the nucleus area A to calculate
the volume as V = A3/2, to position these data points in Fig. 4.
Considering all non-fluorescent cells, we obtained a mean of
γd3C3 + γ
d
4C4 which is slightly higher than when selecting cells as
described above (see also Fig. S12†), but in both cases the
values are below those observed for the fluorescent cells attribu-
Fig. 3 TPF z-stack of a Fucci2aR liver bile duct organoid, showing mVenus as a marker of the S/G2/M phase in the cell cycle. (a) Single xy plane. (b)
zx plane at the line indicated in the xy plane. Images are shown on an intensity grey scale from 0 to 1.2 × 106 photoelectrons per second. (c) 3D ren-
dering of the TPF z-stack. (d and e) TPF versus nucleus volume for each fluorescent cell across the 3D-stack, shown as detected photon rate inte-
grated over each nucleus volume (d) and as average photon rate over the nucleus volume (e).
Paper Analyst



























































































ted to the S/G2 phase, and in line with the lower values seen in
the other phases, consistent with our interpretation. It should
be noted that the limited number of fluorescent cells available
in this study implies that the analysis has a modest statistical
significance, hence the results are to be taken as indicative. The
emphasis here is on the quantitative data analysis pipeline pre-
sented, offering a valuable methodology for investigating quan-
titative chemically signatures of the cell cycle with hyperspectral
CARS microscopy.
3.2. Brain tissue with GBM
In this section, we report our work on brain tissues obtained
from mice xenografted with either eGFP-labelled GBM stem
cells (GSC) or eGFP-labelled non-stem GBM cells (NGC). The
aim was to investigate if hyperspectral CARS microscopy can
separate normal brain tissue from cancerous cells, and if
tumours derived from GSC versus NGC can be distinguished.
eGFP labelling enables positive correlation with CARS
imaging. As discussed in section 3.1, signal bleed through
between CARS and TPF can occur and needs to be corrected
for. The two-photon excitation and emission spectra for eGFP
are displayed in Fig. 1(c) together with the spectra of the TPE
beam and the TPF and CARS PMT QE. The TPE beam spec-
trum overlaps well with the eGFP excitation spectrum, and the
eGFP emission overlaps well with the TPF PMT QE. There is
also a significant overlap of the eGFP emission with the CARS
PMT QE. We can therefore expect to see eGFP emission in
both the TPF and CARS PMTs. This is confirmed experi-
mentally, as reported in Fig. 5(a and d), showing the TPF and
CARS PMT signals when the sample is excited only by the TPE
beam. Fig. 5(b and e) illustrates the detected signal when the
sample is excited only by the CARS (pump and Stokes) beam,
at 2850 cm−1 IFD. We observe a strong signal in the CARS PMT
from lipids and proteins in the cell cytoplasm. In the TPF
PMT, in addition to the two-photon excited auto-fluorescence,
predominantly generated by the pump pulse (similar to what
described in section 3.1), we also see a substantial contri-
bution from the eGFP emission. This is a result of the signifi-
Fig. 4 Overview of the FSC3 analysis on Fucci2aR liver bile duct organoids. Images C1 to C6 are the concentration maps of the corresponding com-
ponents, on a grey scale from 0 to M as indicated in vol/vol units. The corresponding dry vol/vol concentrations are given in parenthesis. Images are
shown for the plane corresponding to the TPF xy section in Fig. 3, and the strongly fluorescent cell visible in the TPF section is indicated as #4, for
reference. (a) Susceptibility spectra of the FSC3 components. (b–d) Dry concentrations of components averaged over the nuclei areas, for the cells
that exhibited mVenus TPF in the nucleus, as a function of the nucleus volume (each data point represents an individual nucleus). Different z-planes
were evaluated (indicated by colours), and data are shown for the planes showing the largest nucleus area (see text). Purple symbols show the mean
(bar: standard error of the mean) of the dry components for two sets of cells having no detectable mVenus fluorescence in the nucleus (see text).
The TPF intensity per nucleus volume is plotted again (same data as in Fig. 3), for direct comparison. Scale bar 10 μm.
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cant spectral overlap of the TPE by the pump beam around
340 nm and the two-photon excitation of eGFP (see Fig. 1).
Fig. 5(c and f) shows the observed signal when the sample is
excited by the pump and Stokes beams out of time overlap. We
can see a weak fluorescence detected in the CARS PMT, due to
two-photon excitation from the individual pump and Stokes
pulses. Although about 20 times weaker than the CARS signal,
this contribution is taken into account in the HIA/FSC3 pipe-
line analysis as described in section 2.4. In the experiments,
TPF excited by the TPE beam and CARS excited by the CARS
beams were acquired sequentially.
Regions of interest (ROIs) containing both cancer cells and
normal tissue were initially found using wide-field epi-fluo-
rescence and DIC imaging, see Fig. 5(g–i) for tissues from
mice implanted with GSC cells. A z-position approximately in
the centre of the 30 μm thick section was located using TPF
imaging. TPF and hyperspectral CARS scans were acquired on
multiple ROIs (6 for GCS-derived tumours and 2 for NGC-
derived tumours) as described in section 2.3.2.2.
Hyperspectral CARS scans were then processed through our
HIA/FSC3 pipeline, as described in section 2.4. For these
samples, using five components in the FSC3 was found to be
Fig. 5 Overview of the CARS and TPF excitation and detected configuration for a mouse brain tissue, following implantation of eGFP-labelled GSCs
in mice (see text). (a–c) Signal detected by the TPF PMT; (d–f ) signal detected the CARS PMT; (a and d) TPF excitation; (b and e) CARS excitation at
2850 cm−1 IFD; (c and f) CARS excitation with the pump and Stokes pulses out of time overlap. Images are shown on a grey scale from 0 to M × 106
photoelectrons per second as indicated. Scale bars: 10 μm. (g) Wide field epi-fluorescence of eGFP; (h) DIC image (0° polariser rotation angle); (i)
overlay of wide field fluorescence (green) and DIC (grey). Scale bar 30 μm. The dashed yellow frame indicates the ROI imaged with CARS and TPF.
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optimal. All 6 ROIs in tissues from mice implanted with GSC
cells were analysed together, hence spectra are a common
basis in the factorisation. Exemplar concentration maps for
one of the ROIs are shown in Fig. 6(C1–C4) in grey scale (all
ROIs are given in Fig. S13 and S15–S20†).
Based on the spectral shape and the spatially-resolved con-
centration maps, the components were assigned to c1: water,
c2: lipid, c3: water + PNA, c4: PNA. Component c5 exhibited a
spectrum that is not physically meaningful, and thus is attrib-
uted to artefacts (see Fig. S14†). Fig. 6 shows the susceptibility
spectra and concentration maps of components c1 to c4 for the
GSC-derived tumour cells. RGB overlays of the concentration
maps of components c2 (red), c4 (green) and c1 + c3 (blue) are
presented in Fig. 6(f–i) for four ROIs. Comparing them with
the corresponding TPF images shown in the figure on the row
above, there is a clear separation between the GSC-derived
cancer and normal brain tissue. Tumour cells in the colour
concentration maps appear green-blue, hence richer in water
Fig. 6 Overview of the hyperspectral CARS FSC3 analysis for GSC-derived tumour cells, showing concentration maps (in vol/vol units) of the spec-
tral components. (a) Component spectra. (C1–C4) concentration maps of the components from one ROI, grey scale from 0 to M as indicated in vol/
vol units. (b–e) TPF images of four ROIs identifying GSC-derived cells; grey scale range 0 to M × 108 photoelectrons per second. (f–i) False colour
maps generated from the overlay of concentrations of components c2 (red), c4 (green), c1 + c3 (blue). All images are on the same RGB scale, from 0
to a colour maximum scale M (vol/vol) with Mred = 0.78, Mgreen = 0.32, Mblue = 1.48. Scale bar: 20 μm.
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Fig. 7 Comparison of the hyperspectral CARS FSC3 analysis on brain sections with GSC-derived and NGC-derived tumours. Samples with NGC-
derived tumours were analysed using as spectral basis the 5 components of the FSC3 analysis from samples with GSC-derived tumours (see Fig. 6).
(a–d) TPF images identifying GSC-derived and NGC-derived cancer cells. Intensity grey scale from 0 to M × 108 photoelectrons per second. (e–h)
False colour maps generated from the overlay of the concentrations of components c2 (red), c4 (green), c1 + c3 (blue). RGB channel range 0 to M
(vol/vol) adjusted as in Fig. 6. Scale bar 20 μm.
Fig. 8 Dry component analysis on brain sections with GSC-derived and NGC-derived tumours. False colour dry concentration maps of the FSC3
components lipid γd2C2 (red) and PNA γ
d
4C4 (green), and the total water concentration 1
P4
i¼2
γdi Ci (blue). (a and b) GSC and (c and d) NGC samples.
Images are on the same RGB scale, from 0 to a colour maximum scale M (vol/vol) with Mred = 0.18, Mgreen = 0.22, Mblue = 1.48. Scale bar: 20 μm. (e
and f) Dry PNA concentration of component γd4C4 spatially averaged over selected areas identified from TPF and false colour maps (see Fig. S24 and
S25† for region maps). (e) GSC-derived tumour regions (solid black squares) compared with regions of normal tissue (hollow squares). The lines
show averages for GSC-derived tumour regions (solid); and normal tissue regions (dashed). (f ) GSC-derived (black squares) and NGC-derived
(magenta triangles) tumour regions for the two GSC and two NGC ROIs shown in (a–d). The solid magenta line shows the average of the NGC-
derived tumour regions; the solid and dashed black lines are the same as in (e).
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and proteins compared to normal tissue. Notably, this finding
is consistent with the fact that tumour cells proliferate faster
than normal cells, hence they need to make more proteins, a
point well recognised in the cell biology literature (for a review
see ref. 44). It is also known that malignant tissue
contains more water than normal tissue. Some of this water is
between cells (interstitial), but there are reports45 showing that
tumour cells contain more water than normal tissue. This
could be explained since, in most instances, tumour cells are
larger than normal cells, albeit this point is not yet fully
understood.
Brain sections containing NGC-derived tumours were also
imaged, at two ROIs, in the same way as described for the sec-
tions containing GSC-derived cancerous tissue. In the HIA/
FSC3 analysis pipeline, the spectral components determined
from the ROIs with GSC-derived cancer cells were used as a
basis (projected FSC3, see section 2.4), allowing for a
direct comparison between the two data sets. Concentration
errors and spectral errors for this factorisation analysis are
shown in Fig. S15–S20† and Fig. S21, S22.† Notably, the spec-
tral errors are similar across the GSC and NGC data sets,
showing that both datasets are well represented by the chosen
common spectral basis. Colour overlays were generated using
the same components mapped in the same RGB order, and
are presented in Fig. 7 alongside the colour maps for two ROIs
in the GSC-derived tumour sections, on the same colour scale
for direct comparison. Firstly, we again note the clear distinc-
tion between cancer cells and the normal tissue. Secondly,
when comparing the GSC-derived and NGC-derived tumours
in the false colour maps we note the GSC-derived cells appear
significantly greener. This shows that tumour cells derived
from GSCs contain more PNA than those derived from NGCs.
A quantitative analysis of the dry concentrations and the water
concentration is shown in Fig. 8 confirming this conclusion.
Indeed, the spatially-resolved dry PNA concentration γd4C4,
across all available ROIs, revealed a mean value of 14.6% vol/
vol (with a standard deviation (SD) of 0.9%) for the GSC-
derived tumour regions compared to a mean of 9% vol/vol (SD
0.5%) in the NGC-derived tumour regions (corresponding to a
1.6 ratio), and a mean of 7.8% vol/vol (SD 0.6%) in the normal
tissue regions (see section S2 iii†). Therefore, our quantitative
hyperspectral CARS technique not only distinguishes between
cancerous versus normal brain tissue, but is also able to
dissect the heterogeneity of cancer cells, and to distinguish
tumours derived from stem cells versus non-stem cells.
4. Conclusions
In conclusion, we have investigated two types of complex mul-
ticellular systems, namely liver organoids and brain tissue sec-
tions, using correlative TPF and hyperspectral CARS
microscopy combined with our recently developed quantitative
and unsupervised data analysis pipeline.
Organoids were maintained alive under hyperspectral CARS
measurements, owing to carefully designed culture and
imaging conditions. They contained a fluorescence construct
(Fucci2aR) which enabled us to selectively tag cells in the
S/G2/M phase via the fluorescent protein mVenus in the
nucleus. Quantitative analysis of the volumetric TPF datasets
showed a correlation between increasing fluorescence intensity
and nucleus volume, which we used to separate the early S
stage from the late S/G2 and G2/M stages. Hyperspectral CARS
microscopy measurements acquired on a sub-set of the
z-planes imaged by TPF provided chemical components, repre-
senting water, proteins, DNA, and lipids, with susceptibility
spectra and concentration maps in physically meaningful
units. An analysis of the average nucleus concentration of the
dry components rich in DNA showed a correlation with the
trend observed in TPF versus nucleus size. The results suggest
that label-free chemically specific hyperspectral CARS
microscopy can highlight the cell subgroup in the S/G2 phase,
when DNA replication has occurred while the cell nucleus size
has not yet significantly expanded, such that the DNA concen-
tration is highest.
Brain tissues were sectioned from mice that had been
implanted with eGFP-labelled glioblastoma stem cells and
non-stem cells. They were imaged with correlative TPF and
hyperspectral CARS, the latter analysed to extract meaningful
chemical components, namely water, proteins and nucleic
acids, lipids, and their concentration maps. Here, we found a
correlation between the TPF image contrast from regions con-
taining eGFP-tagged cancer cells and the CARS chemical con-
trast from regions rich in proteins, clearly distinct from areas
containing normal tissue. Remarkably, we were also able to
distinguish cancer cells derived from implanted GSCs versus
NGCs, on the basis of the relative protein content. Specifically
we found that tumour cells derived from GSCs are significantly
richer in proteins and nucleic acids (by a factor of 1.6 in mean
PNA concentration value) compared to those derived from
NGCs.
Overall, these results highlight the potential of quantitative
hyperspectral CARS microscopy to become an enabling techno-
logy in biomedical research, capable of dissecting the complex-
ity of living organs and tissues via the label-free identification
of chemically distinct subcellular populations non-invasively,
offering significant opportunities in e.g. 3D cancer biology.
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